TABLE 7.
Molecular docking analysis of HSP90AA1 and the drugs.
| Core target | Ligand | Binding energy (kcal/mol) |
|---|---|---|
| HSP90AA1 | Trastuzumab | −7.3 |
| Lapatinib | −9.2 | |
| Neratinib | −7.8 | |
| Tucatinib | −9.6 | |
| Tanespimycin | −6.9 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.